Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06541002

A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors

Led by Massachusetts General Hospital · Updated on 2026-03-19

300

Participants Needed

3

Research Sites

274 weeks

Total Duration

On this page

Sponsors

M

Massachusetts General Hospital

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research study is evaluating the efficacy of a novel self-administered digital application for improving sexual health outcomes, quality of life, and psychological distress in hematopoietic stem cell transplant survivors.

CONDITIONS

Official Title

A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged over 18 years who had autologous or allogeneic hematopoietic stem cell transplant more than three months before enrolling
  • Screen positive for distressing sexual health concerns based on NCCN survivorship guidelines screening questions
Not Eligible

You will not qualify if you...

  • Unable to understand English or Spanish as SHIFT is only available in these languages
  • Presence of major uncontrolled psychiatric disorder or cognitive condition preventing informed consent or study participation, as judged by the treating clinician
  • Relapsed disease requiring treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

University of Miami

Coral Gables, Florida, United States, 33124

Not Yet Recruiting

2

Massachusetts General Hospital (MGH)

Boston, Massachusetts, United States, 02114

Actively Recruiting

3

Fox Chase Cancer Center

Philadelphia, Pennsylvania, United States, 19111

Not Yet Recruiting

Loading map...

Research Team

A

Areej El-Jawahri, MD

CONTACT

S

Sajeewani Samarakoon, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here